Search for Clinical Trial Results

Inclusion Body Myositis - 25 Studies Found
Status | Study |
Completed |
Study Name: Arimoclomol in Sporadic Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2008-10-08 Interventions:
|
Completed |
Study Name: Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis Condition: Sporadic Inclusion Body Myositis Date: 2011-08-12 Interventions:
|
Completed |
Study Name: Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis Condition: Sporadic Inclusion Body Myositis (sIBM) Date: 2014-03-20 Interventions: Drug: BYM338 (Bimagrumab) |
Completed |
Study Name: Lithium in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis Date: 2009-06-08 |
Not yet recruiting |
Study Name: Study of Arimoclomol in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis Date: 2016-04-25 Interventions:
|
Completed |
Study Name: Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2009-05-11 |
Completed |
Study Name: Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2008-12-04 Interventions: Drug: Etanercept 50 milligrams subcutaneously every week |
Active, not recruiting |
Study Name: An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 Condition: Sporadic Inclusion Body Myositis Date: 2015-07-09 Interventions:
|
Completed |
Study Name: Blood-flow Restricted Exercise in Inclusion Body Myositis Condition: Sporadic Inclusion Body Myositis Date: 2014-12-10 Interventions:
|
Active, not recruiting |
Study Name: Natalizumab in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis (IBM) Date: 2013-05-31 Interventions: Drug: Natalizumab Other Name: Tysabri |